Status:
UNKNOWN
Hepatitis B Virus Infection in Immunized Children With HBsAg-positive Parents
Lead Sponsor:
Qiu Li
Conditions:
Hepatitis b Virus Infection
Eligibility:
All Genders
Brief Summary
Hepatitis B virus (HBV) infection is a major public health problem facing the world, with more than 2 billion people infected with HBV. There are more than 400 million chronic carriers, and 75% of car...
Detailed Description
Hepatitis B virus (HBV) infection is a major public health problem facing the world, with more than 2 billion people infected with HBV. Although since 1986 the World Health Organization (WHO has reduc...
Eligibility Criteria
Inclusion
- The father or (and) mother is HBV-infected (pre-pregnancy or present)；
- Children is vaccinated with hepatitis B vaccine after birth;
Exclusion
- Children with HBV infection;
- Participants agreed to undergo clinical follow-up studies.
Key Trial Info
Start Date :
July 4 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2023
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT03864263
Start Date
July 4 2019
End Date
December 31 2023
Last Update
July 8 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chongqing Children's Hospital of Chongqing Medical University
Chongqing, China